U.S. approves Leqembi, a drug that modestly slows Alzheimer's January 06, 2023 U.S. health officials on Friday approved a closely watched Alzheimer's drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and their doctors will have to carefully weigh. Labels: CBC | Health News health Share to: Twitter Facebook URL Print Email
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.